Skip to main content
. 2018 Apr 6;9:337. doi: 10.3389/fphys.2018.00337

Figure 1.

Figure 1

(A) EGF levels in the serum of patients at baseline and after 1 month of treatment. Black circle: patient randomized to clopidogrel. White square: patient randomized to ticagrelor. **P < 0.01; (B) EGF levels of patients representation before and after treatments. Orange circle: patient randomized to clopidogrel. Blue squares: patient randomized to ticagrelor. **P < 0.01.